OK
About Company
Technology
Investor Relations
Contact Us

latest news

Appendix 4C Quarterly Report

BioDiem regains Japanese Rights

Extension of Co-operative Research Development Agreement

 WHO issues a further sublicence of LAIV

Appendix 4C Quarterly Report

LAIV Proof of Concept Trial

Results of AGM

AGM Presentation

Chairman's Address to Shareholders  

WHO Sub-licenses BDM's LAIV Technology

Agreement with PATH for Prototype Pandemic Influenza Vaccine

Completion of Phase I Clinical Trial Recruitment for LAIV

Notice of Meeting & Proxy Form

Annual Report - Complete 

Annual Report - Chairman's Review

Annual Report - Editorial

Annual Report - Financials

Investor Information

ASX Announcements

Financial Results

ASX Link

© BioDiem 2005Home | Sitemap | Privacy Policy